Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,609 | -2,680 | -11,715 | -9,879 | -7,980 |
| Depreciation Amortization | 1 | 0 | 2 | 2 | 1 |
| Other Working Capital | 3,683 | 1,842 | 3,235 | 1,899 | 936 |
| Other Operating Activity | 156 | 78 | 352 | 274 | 190 |
| Operating Cash Flow | $-1,769 | $-760 | $-8,127 | $-7,705 | $-6,853 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2 | -2 | -2 |
| Investing Cash Flow | $N/A | $0 | $-2 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,975 | 2,019 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 242 | 0 | 0 |
| Financing Cash Flow | $1,975 | $2,019 | $242 | $0 | $N/A |
| Exchange Rate Effect | 32 | 17 | 68 | 74 | 68 |
| Beginning Cash Position | 125 | 125 | 7,943 | 7,943 | 7,943 |
| End Cash Position | 362 | 1,402 | 125 | 311 | 1,157 |
| Net Cash Flow | $238 | $1,277 | $-7,818 | $-7,632 | $-6,787 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,769 | -760 | -8,127 | -7,705 | -6,853 |
| Capital Expenditure | N/A | 0 | -2 | -2 | -2 |
| Free Cash Flow | -1,769 | -760 | -8,128 | -7,706 | -6,855 |